Pfizer
Jim Cafone has extensive work experience in supply chain management and operations. Jim has been with Pfizer since 1993, where they held various leadership positions. From 1993 to 2018, they held roles such as Director of Operations Analysis, Senior Director of Information Management, and Senior Director of Pharma Supply Planning. In these roles, they were responsible for overseeing logistics, planning, and information technology initiatives to improve supply chain connectivity. From 2002 to 2003, they served as the Senior Director of North American Supply & Logistics, where they managed distribution centers and supported sales operations. Jim's most recent roles at Pfizer include Vice President of Supply Network Services, Vice President of Supply Operations, and Vice President of Strategy & Business Operations. Jim is currently serving as the Senior Vice President of Global Supply Chain at Pfizer.
Jim Cafone completed their education with a B.S. in Industrial Engineering from the University of Rhode Island in 1988. Jim then obtained an M.S. in Manufacturing Engineering from the same university between 1988 and 1990. Jim later pursued an M.S. in Technology Management from The Wharton School, completing it between 1999 and 2001.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.